Stack of gold bars close up background, shiny gold ingot
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Alkane Resources (ASX:ALK) has announced its gold production metrics for full year FY24 coming in at 57,217oz – brushing just short of the upper range of its upgraded guidance of 55Koz – 58Koz.

Preliminary all in costs for the full year are anticipated to be within the updated guidance of A$2.15K – A$2.35K.

Alkane is now sitting on cash, bullion and investments totalling $54.5M as at the last day of June.

Notably, the $295M market cap company expects to produce between 70Koz – 80Koz of gold in FY25 with an all in cost of A$2.4K – A$2.6K.

Under Alkane’s five year plan released in late June, the company anticipates all in costs to fall to A$1.9K – A$2.1K “over the entire five-year plan.”

Management pointed to the productivity of the company’s Tomingley Gold Operations in NSW.

“Tomingley is steadily increasing production from the Roswell underground,” Alkane MD Nic Earner said.

“Tomingley is now performing well, and the paste plant and flotation circuit upgrades remain on schedule.”

During Q4 of FY24, Alkane drew A$42.8M from a Macquarie bank debt facility totalling A$60M. The company also noted its $54M in cash does not include investment positions in Caldius Resources, for which administrators were appointed only last week. Shareholders will know the full impairment in August when the company releases its annual.

Alkane shares were up 3% out of the gate on Thursday trades according to Cboe live pricing.

ALK last traded at 50.5cps.

ALK by the numbers
More From The Market Online
Landscape in Paraiba State, Brazil

Power gets set for 1000-metre maiden drilling program in Brazil

Power Minerals Ltd is planning a maiden drilling program to 1000 metres to test targets at…
Red Centre in the Northern Territory

Charger shares move up as it completes Bynoe acquisition in NT

Charger Metals NL has completed its acquisition of the Bynoe Lithium Project, comprising a largely unexplored…
Pancreatic cancer 3D illustration

Smallcap Radiopharm notches +12% jump on pancreatic cancer imaging win

Radiopharm Theranostics (ASX:RAD) has seen the safety profile of its pancreatic cancer imaging drug RAD 301…
Copper trading USD concept

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment –…